#USA #New York #Canton Network #Tharimmune #Jill Sommers

Tharimmune Strengthens Board of Directors with New Appointments

Tharimmune, Inc., a pioneer in the integration of Canton Coin into public trading, has recently announced the appointment of Jill Sommers and William Wiley to its Board of Directors. The decision took effect on February 1, 2026, as part of the company's commitment to enhance its governance while it embarks on a mission to modernize financial infrastructure through the Canton Network.

Expertise Meets Innovation

Under the leadership of CEO Mark Wendland, Tharimmune is moving forward with a strategic digital asset treasury plan aimed at revitalizing traditional financial markets. The new board members are not only seasoned professionals but also bring valuable insights that align perfectly with the company's ambitious goals.

Meet Jill Sommers

Jill Sommers is a prominent figure in financial regulation and has nearly 30 years of experience in derivatives markets. She served two terms as a Commissioner for the U.S. Commodity Futures Trading Commission (CFTC), where she contributed significantly to the regulatory landscape. Most recently, she was the Chair of the Derivative Practice Group at Potamak Global Partners until March 2025. Her previous roles include key positions at the International Swaps and Derivatives Association (ISDA) and the Chicago Mercantile Exchange, where she cultivated her extensive regulatory expertise.

In her own words, "I am thrilled to bring my experience in derivatives regulation, corporate governance, and public policy to support the modernization of financial infrastructure. I look forward to collaborating with other members of the Board as Tharimmune advances its vision for a compliant, blockchain-enabled financial system."

Introducing William Wiley

William Wiley complements Sommers' regulatory expertise with his extensive operational leadership in capital markets. Currently, he serves as Head of the Equities and Latency Sensitive Business Unit at DRW and has a wealth of experience in managing complex global operations. His previous role as Chief Operating Officer at DRW's Equities and Latency Sensitive Business Unit included overseeing daily operations and tactical enhancements of a multi-asset electronic trading platform.

Wiley expressed his enthusiasm for joining Tharimmune by stating, "I am honored to join Tharimmune's Board and contribute to the firm's efforts to move our financial system off of aging, legacy technology and into a modern era. I strongly believe in the transformative nature of the Canton Network and I am excited to help guide Tharimmune's unique vision for participating in the ecosystem to drive shareholder value."

The Road Ahead for Tharimmune

Tharimmune has rolled out an innovative digital asset treasury strategy, initially established in November 2025. This strategy not only focuses on increasing value through Canton Coin acquisition but also emphasizes operating as a Super Validator. The firm aims to invest in applications created around the Canton Network that enhance institutional utility and encourage greater adoption across capital markets.

In a world where financial systems are often hamstrung by outdated technology, Tharimmune's strategic direction suggests that the company is poised to make significant contributions to both the technological and regulatory landscapes of financial markets. By integrating sophisticated blockchain solutions and embracing digital asset strategies, Tharimmune is on the path toward redefining financial infrastructure.

About Tharimmune

Tharimmune, Inc. trades on NASDAQ under the symbol THAR and is the first publicly listed company to utilize Canton Coin in its operations. The company seeks to foster blockchain adoption in institutional settings while concurrently engaging in clinical-stage biotech research and development.

For more information, please visit Tharimmune's website.

Disclaimer

This article contains forward-looking statements regarding Tharimmune's strategies and future plans. Actual results may differ significantly from these expectations due to various risks and uncertainties, which are discussed in the company's filings with the U.S. Securities and Exchange Commission.